Tamsulosin Hydrochloride
Product Images NDC 54868-4437

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 54868-4437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.4 mg Capsule Bottle Label)

Label for Tamsulosin Hydrochloride 0.4 mg capsules from Physicians Total Care, Inc. The package contains 90 capsules. The label includes cautions about federal law, dosing instructions, storage directions, and lot and expiration information.*

FDA Label Image

Chemical Structure (Tamsulosin 01)

Chemical structure of Tamsulosin Hydrochloride showing molecular components including aromatic rings, functional groups, and hydrochloride salt.*

FDA Label Image

Figure 1 (Tamsulosin 02)

A pharmacokinetic curve showing plasma concentration (ng/mL) of Tamsulosin Hydrochloride over time (hours). The graph compares concentration levels between fasted and fed states, with fasted shown as a dashed line and fed as a solid line, illustrating different absorption profiles up to 36 hours.*

FDA Label Image

Figure 2a (Tamsulosin 03)

A line graph depicting mean change over the duration of treatment in weeks for three groups: 0.8 mg dosage, 0.4 mg dosage, and placebo. The x-axis represents weeks of treatment (0 to 13), and the y-axis shows mean change values. The graph compares the effects of two Tamsulosin Hydrochloride doses and placebo over time.*

FDA Label Image

Figure 2b (Tamsulosin 04)

A line graph showing the mean change over time (weeks) in response to different treatments for Tamsulosin Hydrochloride 0.4 mg, 0.8 mg, and placebo. The x-axis represents the duration of treatment in weeks, and the y-axis represents the mean change. The graph includes data points and lines for each treatment group, with a legend identifying the 0.8 mg (circle), 0.4 mg (triangle), and placebo (square) treatments.*

FDA Label Image

Figure 3a (Tamsulosin 05)

A line graph depicting mean change in mL/sec over a 13-week treatment duration. It compares three groups: Tamsulosin Hydrochloride 0.8 mg, 0.4 mg, and placebo. The x-axis shows weeks of treatment; the y-axis shows mean change. Treatment groups show greater improvement compared to placebo.*

FDA Label Image

Figure 3b (Tamsulosin 06)

A line graph showing mean change in mL/sec on the vertical axis versus duration of treatment in weeks on the horizontal axis. The graph compares changes for three treatments: 0.8 mg, 0.4 mg, and placebo over a 13-week period with data points and trends indicated for each treatment group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.